LONDON, ON, Feb. 26, 2013 /CNW/ - London Health Sciences Centre (LHSC)
continues its tradition of innovation as it is the first in North
America to use a new blood circulation device and first in the world to
use the device in cardiac surgery.
Since December, Dr. Bob Kiaii, cardiac surgeon, and the rest of the
cardiac surgery team at LHSC, has been treating patients recovering
from heart surgery with the new blood circulation device, named geko™,
to help manage swelling resulting from excess fluids following cardiac
surgery, a condition known as post-operative edema.
"The device offers patients a drug-free treatment option for a common
condition following cardiac surgery and simplifies current strategies
to eliminate excess fluids," says Dr. Kiaii. "This is important because
excess fluids impede oxygen delivery and wound healing, compromise
pulmonary function, and delay resumption of bowel function."
The size of a wrist-watch and worn behind the knee, the self-contained
geko™ device is designed to increase blood flow by activating the
muscle pumps in the lower leg that return blood to the heart, emulating
the blood flow rate normally achieved by walking (up to 70 per cent),
without the patient having to move or exert energy. Patients can apply
the battery powered device themselves and have the control to turn it
off or on.
"Dr. Kiaii and his team continue to build upon London Health Sciences
Centre's legacy of innovation," says Bonnie Adamson, President and CEO,
LHSC. "This is another example of LHSC utilizing advanced technologies
to improve outcomes for the patients we serve."
Dennis Findlay of London, Ontario was the first patient offered the new
treatment by Dr. Kiaii immediately after his triple-bypass surgery in
December. "I wore it every day while I was in hospital. It was painless
and barely noticeable and I'm grateful it helped my recovery,"
Approximately 60 patients at LHSC have benefited from the device as part
of their treatment plan. "Early observational use of the geko™ device
has shown promise and we are planning to conduct a controlled trial to
further investigate its health benefits," continues Dr. Kiaii.
Bernard Ross, CEO Firstkind Ltd, device manufacturer, said "Precise
management of fluids and electrolytes is a fundamental part of a
patient's overall surgical treatment. Through the unique differential
of superior blood flow, we believe the geko™ device is well placed to
deliver simplicity of patient care, enhanced patient mobility, better
patient outcomes and substantial cost savings for health services
globally through a reduced length of patient stay."
About London Health Sciences Centre
London Health Sciences Centre has been in the forefront of medicine in
Canada for 138 years and offers the broadest range of specialized
clinical services in Ontario. Building on the traditions of its
founding hospitals to provide compassionate care in an academic
teaching setting, London Health Sciences Centre is home to Children's
Hospital, University Hospital, Victoria Hospital, the Kidney Care
Centre, two family medical centres, and two research institutes -
Children's Health Research Institute and Lawson Health Research
Institute, a joint research initiative with St. Joseph's Health Care
London. As a leader in medical discovery and health research, London
Health Sciences Centre has a history of over 65 international and
national firsts and attracts top clinicians and researchers from around
the world. As a regional referral centre, London Health Sciences Centre
cares for the most medically complex patients including critically
injured adults and children in southwestern Ontario and beyond. The
hospital's nearly 15,000 staff, physicians, students and volunteers
provide care for more than one million patient visits a year. For more
information visit www.lhsc.on.ca
Visit the LHSC Media web site at www.lhsc.on.ca/media
Like us on Facebook at LHSC Canada, follow us on Twitter @LHSCCanada and watch us on YouTube at LHSCCanada.
SOURCE: London Health Sciences Centre
For further information:
For media inquiries contact:
Corporate Communications and Public Relations
London Health Sciences Centre
519-685-8500, ext. 75155
Call LHSC Switchboard at 519-685-8500 and ask to page the communication consultant on-call